These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 28365180)

  • 1. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Onco-Cardiology - From the Standpoint of Cardiology].
    Shioyama W
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2052-2057. PubMed ID: 29361616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concomitant management of cancer therapy and cardiac therapy.
    Salvatorelli E; Menna P; Cantalupo E; Chello M; Covino E; Wolf FI; Minotti G
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2727-37. PubMed ID: 25596534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-oncology: management of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2019; 8():. PubMed ID: 30755794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [First guidelines on pediatric cardio-oncology from the Brazilian Society of Cardiology].
    Seber A; Miachon AS; Tanaka AC; Spínola e Castro AM; Carvalho AC; Petrilli AS; Macedo CR; Nars CC; Terzian CN; Castro CG; Santos CC; Guerra CC; Silva DC; Bassi DU; Azeka E; Feitosa FA; Hamamoto F; Szarf G; Lederman HM; Rigon HJ; Jatene IB; Mota IC; Perrud JA; Soares J; Gutierrez JA; Perin JP; Soares Jdos S; Catani LH; Tsai LY; Vianna LC; Paiva MG; Santos MJ; Ishigai MM; Diógenes MS; Alves MT; Piedade MT; Parreiras M; Cypriano M; Negrini Nda S; Campos Filho O; Figueiredo PA; Novaes PE; Camargo PR; Maia Pdos S; Petrilli R; Arduini RG; Gouveia RV; Teruya SB; Moisés VA; Morais VL;
    Arq Bras Cardiol; 2013 May; 100(5 Suppl 1):1-68. PubMed ID: 23783435
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioncology: state of the heart.
    Todaro MC; Oreto L; Qamar R; Paterick TE; Carerj S; Khandheria BK
    Int J Cardiol; 2013 Sep; 168(2):680-7. PubMed ID: 23639459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
    Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving paediatric cardiologists' awareness about the needs of childhood cancer survivors: results of a single-centre directed educational initiative.
    Rose-Felker K; Effinger K; Kelleman MS; Sachdeva R; Meacham LR; Border WL
    Cardiol Young; 2019 Jun; 29(6):808-812. PubMed ID: 31280730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.
    Alexandre J; Cautela J; Ederhy S; Damaj GL; Salem JE; Barlesi F; Farnault L; Charbonnier A; Mirabel M; Champiat S; Cohen-Solal A; Cohen A; Dolladille C; Thuny F
    J Am Heart Assoc; 2020 Sep; 9(18):e018403. PubMed ID: 32893704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-oncology: the new frontier of clinical and preventive cardiology.
    Paris S; Tarantini L; Navazio A; Faggiano P
    Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
    Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
    Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international survey of healthcare providers' knowledge of cardiac complications of cancer treatments.
    Peng J; Rushton M; Johnson C; Brezden-Masley C; Sulpher J; Chiu MG; Graham ID; Dent S
    Cardiooncology; 2019; 5():12. PubMed ID: 32154018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.